Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · IEX Real-Time Price · USD
400.10
+6.80 (1.73%)
May 20, 2024, 12:14 PM EDT - Market open
Medpace Holdings Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Medpace Holdings stock have an average target of 448.6, with a low estimate of 395 and a high estimate of 480. The average target predicts an increase of 12.12% from the current stock price of 400.10.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MEDP stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 3 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $453 → $464 | Strong Buy | Maintains | $453 → $464 | +15.97% | Apr 24, 2024 |
| Baird | Baird | Buy Maintains $446 → $454 | Buy | Maintains | $446 → $454 | +13.47% | Apr 24, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $340 → $450 | Hold → Strong Buy | Upgrades | $340 → $450 | +12.47% | Apr 23, 2024 |
| Deutsche Bank | Deutsche Bank | Hold Initiates $395 | Hold | Initiates | $395 | -1.27% | Mar 18, 2024 |
| UBS | UBS | Strong Buy Maintains $452 → $480 | Strong Buy | Maintains | $452 → $480 | +19.97% | Mar 8, 2024 |
Financial Forecast
Revenue This Year
2.23B
from 1.89B
Increased by 18.20%
Revenue Next Year
2.59B
from 2.23B
Increased by 16.29%
EPS This Year
10.82
from 8.88
Increased by 21.87%
EPS Next Year
12.94
from 10.82
Increased by 19.56%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.3B | 2.8B | 3.3B | 3.4B | 3.8B |
| Avg | 2.2B | 2.6B | 3.0B | 3.2B | 3.7B |
| Low | 2.1B | 2.4B | 2.7B | 3.1B | 3.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 22.6% | 24.4% | 28.8% | 13.9% | 16.3% |
| Avg | 18.2% | 16.3% | 14.8% | 9.2% | 13.0% |
| Low | 12.9% | 8.9% | 5.1% | 3.6% | 8.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.36 | 13.59 | 16.86 | 17.98 | 20.32 |
| Avg | 10.82 | 12.94 | 15.20 | 17.46 | 19.74 |
| Low | 10.23 | 11.73 | 13.44 | 16.78 | 18.96 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 27.9% | 25.5% | 30.3% | 18.2% | 16.3% |
| Avg | 21.9% | 19.6% | 17.5% | 14.9% | 13.0% |
| Low | 15.2% | 8.4% | 3.8% | 10.3% | 8.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.